首页 | 本学科首页   官方微博 | 高级检索  
     

siRNA抑制Ku80表达后对宫颈癌HeLa细胞增殖的影响
引用本文:Zhuang L,Yu SY,Huang XY,Gao QL,Xiong H,Leng Y. siRNA抑制Ku80表达后对宫颈癌HeLa细胞增殖的影响[J]. 癌症, 2007, 26(3): 252-257
作者姓名:Zhuang L  Yu SY  Huang XY  Gao QL  Xiong H  Leng Y
作者单位:华中科技大学同济医学院,附属同济医院肿瘤中心,湖北,武汉,430030;华中科技大学同济医学院,附属同济医院肿瘤中心,湖北,武汉,430030;华中科技大学同济医学院,附属同济医院肿瘤中心,湖北,武汉,430030;华中科技大学同济医学院,附属同济医院肿瘤中心,湖北,武汉,430030;华中科技大学同济医学院,附属同济医院肿瘤中心,湖北,武汉,430030;华中科技大学同济医学院,附属同济医院肿瘤中心,湖北,武汉,430030
摘    要:背景与目的:Ku80为细胞受辐射后DNA双链断裂(DNA double strand break,DSB)的主要修复蛋白.现阶段关于Ku80的研究主要集中在DSB修复方面,其他方面研究较少.本研究建立利用siRNA抑制Ku80表达的宫颈癌HeLa细胞模型,以此探讨Ku80在细胞增殖方面的作用.方法:构建靶向抑制Ku80的siRNA表达载体,转染HeLa细胞,筛选稳定表达siRNA的转化克隆;Western blot检测Ku80表达变化:克隆形成实验、MTT法和裸鼠皮下瘤形成实验分别检测细胞克隆形成率及细胞在体外和体内的增殖情况.结果:构建表达质粒pKu80-siRNA与pNeg-siRNA转染HeLa细胞,G418筛选后获得稳定转染克隆,Western blot分析表明转染pKu80-siRNA后的细胞Ku80蛋白表达受到明显抑制,将其命名为HeLa/Ku80-siRNA;转染pNeg-siRNA的HeLa细胞克隆形成率为0.62±0.02,而HeLa/Ku80-siRNA细胞的克隆形成率为0.46±0.05,明显低于对照细胞(t=5.11,P<0.01);MTT显示细胞培养48 h和72 h时,HeLa/Ku80-siRNA细胞的增殖率均显著低于对照细胞(P<0.05);裸鼠皮下瘤生长实验示种植25天时,HeLa/Ku80-siRNA细胞种植瘤的平均体积为(18.92±3.60)mm3,明显低于对照细胞种植瘤体积(194.88±30.61)mm3,(t=12.69,P<0.01).结论:稳定转染及siRNA技术建立的Ku80表达抑制克隆可以成为简单实用的细胞模型:Ku80-siRNA抑制Ku80的表达后可以在体内外抑制HeLa细胞的增殖.

关 键 词:Ku80  小干扰RNA  稳定转染  细胞增殖  宫颈肿瘤  HeLa细胞
文章编号:1000-467X(2007)03-0252-06
修稿时间:2006-07-28

Effect of Ku80 expression inhibition by RNA interference on proliferation of cervical carcinoma cell line HeLa
Zhuang Liang,Yu Shi-Ying,Huang Xiao-Yuan,Gao Qing-Lei,Xiong Hua,Leng Yan. Effect of Ku80 expression inhibition by RNA interference on proliferation of cervical carcinoma cell line HeLa[J]. Chinese journal of cancer, 2007, 26(3): 252-257
Authors:Zhuang Liang  Yu Shi-Ying  Huang Xiao-Yuan  Gao Qing-Lei  Xiong Hua  Leng Yan
Affiliation:Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P. R. China
Abstract:BACKGROUND & OBJECTIVE: Ku80 is a key protein plays a role in repairing DNA double strand break (DSB) after irradiation. There are a few studies about other roles of Ku80 except DSB repair. This study was to inhibit Ku80 expression in cervical carcinoma cell line HeLa with small interfering RNA (siRNA), and explore its effect on cell proliferation. METHODS: Plasmids pKu80-siRNA and pNeg-siRNA (negative control) were constructed and transfected into HeLa cells. The expression of Ku80 in HeLa cells was detected by Western blot. The proliferation of HeLa cells in vitro and in vivo was determined by clone formation assay, MTT assay, and subcutaneous tumor formation in nude mice. RESULTS: Two cell clones were screened from pKu80-siRNA-and pNeg-siRNA-transfected HeLa cells. Ku80 expression in HeLa cells was suppressed markedly after transfection of pKu80-siRNA; this clone was named Hela/Ku80-siRNA. The clone formation efficiency was significantly lower in HeLa/Ku80-siRNA cells than in control cells (0.46+/-0.05 vs. 0.62+/-0.02, t=5.11, P<0.01). The proliferation rate was significantly lower in HeLa/Ku80-siRNA cells than in control cells at 48 h and 72 h after transfection (P<0.05). At the 25th day after subcutaneous transplantation in nude mice, the tumor volume was significantly smaller in HeLa/Ku80-siRNA group than in control group [(18.92+/-3.60) mm(3) vs. (194.88+/-30.61) mm(3), t=12.69, P<0.01]. CONCLUSIONS: We successfully established a cell model that Ku80 expression is suppressed almost completely by siRNA. Ku80 inhibition inhibits the proliferation of HeLa cells in vivo and in vitro.
Keywords:Ku80   Small interfering RNA   Stable transfection   Cell proliferation   Cervical neoplasm   HeLa cell
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号